Ultralife Corp. buy Benchmark Co.
Start price
15.11.24
/
50%
€7.30
Target price
15.11.25
€13.29
Performance (%)
-20.41%
Price
29.09.25
€5.65
Summary
This prediction is currently active. The prediction for Ultralife Corp. disappoints with a performance of -20.41%. This prediction currently runs until 15.11.25. The prediction end date can be changed by Benchmark_Co_ at any time. Benchmark_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Ultralife Corp. | -5.405% | -5.405% |
| iShares Core DAX® | 0.696% | -0.706% |
| iShares Nasdaq 100 | 0.033% | 4.900% |
| iShares Nikkei 225® | -0.420% | 6.468% |
| iShares S&P 500 | 0.153% | 2.911% |
Comments by Benchmark_Co_ for this prediction
In the thread Ultralife Corp. diskutieren
Ultralife Co. (NASDAQ: ULBI) had its "buy" rating re-affirmed by analysts at Benchmark Co.. They now have a $14.00 price target on the stock.
Ratings data for ULBI provided by MarketBeat